HB 690 Summary

• Extends the time frame for supplying Schedule II controlled substance prescriptions from seven days to thirty days for qualifying patients under Hawaii's "Our Care, Our Choice Act" (chapter 327L)

• Exempts qualifying patients under chapter 327L from the seven-day limit on initial concurrent prescriptions of opioids and benzodiazepines

• Exempts prescriptions issued to qualifying patients under chapter 327L from the requirement to check the state electronic prescription accountability system before prescribing Schedule II, III, or IV controlled substances

• Exempts qualifying patients under chapter 327L from classification as "qualifying opioid therapy patients" subject to opioid dosing restrictions and informed consent requirements

• Effective date is July 1, 2050, with provision that amendments to prescription fill timelines are preserved when statutory provisions are reenacted on June 30, 2023